Research and Markets: Hematological Tumor - Pipeline Review, H2 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/sz78t7/hematological) has announced the addition of Global Markets Direct's new report "Hematological Tumor - Pipeline Review, H2 2012" to their offering.

“Hematological Tumor - Pipeline Review, H2 2012”

'Hematological Tumor - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hematological Tumor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hematological Tumor.

Scope

- A snapshot of the global therapeutic scenario for Hematological Tumor.

- A review of the Hematological Tumor products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Hematological Tumor pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Involved in Hematological Tumor Therapeutics Development

• Genzyme Corporation
  
• F. Hoffmann-La Roche Ltd.
  
• Sanofi-Aventis
  
• AstraZeneca PLC
  
• Eli Lilly and Company
  
• MedImmune LLC
  
• Novartis AG
  
• Onyx Pharmaceuticals, Inc.
  
• Merck KGaA
  
• Access Pharmaceuticals, Inc.
  
• 4SC AG
  
• Marshall Edwards, Inc.
  
• Curis, Inc.
  
• Jazz Pharmaceuticals, Inc.
  
• Oryzon
  
• Nerviano Medical Sciences S.r.l.
  
• Aegera Therapeutics Inc.
  
• Altor BioScience Corporation
  
• Arno Therapeutics, Inc.
  
• ACT Biotech, Inc.
  
• Stemline Therapeutics, Inc.
  
• NOXXON Pharma AG
  
• Fate Therapeutics, Inc.
  
• Esperance Pharmaceuticals, Inc.
  
• Y's Therapeutics Co., Ltd.
  
• Biokine Therapeutics Ltd.
  
• Cylene Pharmaceuticals, Inc.
  
• Jiangsu Kanion Pharmaceutical Co., Ltd.
  
• XBiotech USA, Inc.
• IkerChem S.L.

For more information visit http://www.researchandmarkets.com/research/sz78t7/hematological

Source: Global Markets Direct